Erbin inhibits transforming growth factor β signaling through a novel Smad-interacting domain
Erbin inhibits transforming growth factor β signaling through a novel Smad-interacting domain
复制标题
DOI:
10.1128/mcb.00132-07
复制
发表时间:
2007-09-01
影响因子:
5.3
通讯作者:
Feng, Xin-Hua
中科院分区:
文献类型:
--
作者:
Dai, Fangyan;Chang, Chenbei;Feng, Xin-Hua
Smad proteins are critical intracellular signaling mediators for the transforming growth factor beta (TGF beta) superfamily. Here, we report that Erbin (for "ErbB2/Her2-interacting protein"), which contains leucine-rich repeats and a PDZ (PSD-95/DLG/ZO-1) domain, interacts specifically with Smad3 and, to a lesser extent, with Smad2 through a novel Smad-interacting domain (SID) adjacent to its PDZ domain. Increased expression of Erbin does not affect the level of TGF beta-induced phosphorylation of Smad2/Smad3, but it physically sequesters Smad2/Smad3 from their association with Smad4 and hence negatively modulates TGF beta-dependent transcriptional responses and cell growth inhibition. An isoform of Erbin encoded by an alternatively spliced transcript in human tissues lacks this SID and fails to inhibit TGF beta responses. Consistently, knockdown of the endogenous Erbin gene with short hairpin RNA enhances TGF beta-induced antiproliferative and transcriptional responses. In addition, Erbin suppresses activin/Smad2-dependent, but not BMP/Smad1-mediated, induction of endogenous gene expression in Xenopus embryos. Therefore, these results define Erbin as a novel negative modulator of Smad2/Smad3 functions and expand the physiological role of Erbin to the regulation of TGF beta signaling.